Home
SDGR
SDGR News

Latest Schrodinger Inc. (SDGR) News on October 30, 2025

Schrödinger (SDGR): Evaluating Valuation as Market Sentiment Remains Quiet

Simply Wall St.

2 months ago

Schrödinger (SDGR): Evaluating Valuation as Market Sentiment Remains Quiet

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire

4 months ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger Reports Encouraging Initial Phase 1 Clinical Data for SGR-1505 at EHA Annual Congress

Business Wire

5 months ago

Schrödinger Reports Encouraging Initial Phase 1 Clinical Data for SGR-1505 at EHA Annual Congress

Argus Research

5 months ago

SDGR: Raising target price to $27.00

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Commercial Officer

Business Wire

5 months ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Commercial Officer

Schrödinger Expands Executive Leadership Team with Appointment of Mannix Aklian as Chief Commercial Officer, Global Head of Software Sales and Marketing

Business Wire

5 months ago

Schrödinger Expands Executive Leadership Team with Appointment of Mannix Aklian as Chief Commercial Officer, Global Head of Software Sales and Marketing

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire

5 months ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger to Present at Jefferies Global Healthcare Conference

Business Wire

5 months ago

Schrödinger to Present at Jefferies Global Healthcare Conference

Leadership Transition at Schrödinger: Richie Jain Named CFO

Insider Monkey

5 months ago

Leadership Transition at Schrödinger: Richie Jain Named CFO

Argus Research

5 months ago

SDGR: Rating increased to a HOLD

Tourmaline shares fall on Phase 2 data; Schrödinger cuts staff

BioPharma Dive

5 months ago

Tourmaline shares fall on Phase 2 data; Schrödinger cuts staff

Schrödinger Announces CFO Appointment

Business Wire

5 months ago

Schrödinger Announces CFO Appointment

Schrödinger to Present Phase 1 Clinical Data on MALT1 Inhibitor SGR-1505 at EHA Annual Congress and International Conference on Malignant Lymphoma

Business Wire

6 months ago

Schrödinger to Present Phase 1 Clinical Data on MALT1 Inhibitor SGR-1505 at EHA Annual Congress and International Conference on Malignant Lymphoma

Argus Research

6 months ago

SDGR: Rating decreased to a SELL

Schrödinger First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

6 months ago

Schrödinger First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Thomson Reuters StreetEvents

6 months ago

Q1 2025 Schrodinger Inc Earnings Call

Schrodinger Inc (SDGR) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ...

GuruFocus.com

6 months ago

Schrodinger Inc (SDGR) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ...

Schrodinger, Inc. (SDGR) Reports Q1 Loss, Tops Revenue Estimates

Zacks

6 months ago

Schrodinger, Inc. (SDGR) Reports Q1 Loss, Tops Revenue Estimates

Schrödinger Reports Strong First Quarter 2025 Financial Results

Business Wire

6 months ago

Schrödinger Reports Strong First Quarter 2025 Financial Results

Is Now An Opportune Moment To Examine Schrödinger, Inc. (NASDAQ:SDGR)?

Simply Wall St.

6 months ago

Is Now An Opportune Moment To Examine Schrödinger, Inc. (NASDAQ:SDGR)?

Argus Research

6 months ago

SDGR: Lowering target price to $25.00

Schrödinger to Present at BofA Securities 2025 Healthcare Conference

Business Wire

6 months ago

Schrödinger to Present at BofA Securities 2025 Healthcare Conference

Schrödinger Presents New Preclinical Data at AACR Annual Meeting

Business Wire

6 months ago

Schrödinger Presents New Preclinical Data at AACR Annual Meeting

Schrödinger, Inc. (SDGR): Among Top Stocks in Bill Gates’ Portfolio with Huge Upside Potential

Insider Monkey

6 months ago

Schrödinger, Inc. (SDGR): Among Top Stocks in Bill Gates’ Portfolio with Huge Upside Potential

Schrödinger to Announce First Quarter 2025 Financial Results on May 7

Business Wire

6 months ago

Schrödinger to Announce First Quarter 2025 Financial Results on May 7

2 ‘Strong Buy’ Stocks That Are Crashing the Market in April

TipRanks

6 months ago

2 ‘Strong Buy’ Stocks That Are Crashing the Market in April

Argus Research

6 months ago

SDGR: What does Argus have to say about SDGR?

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire

6 months ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

An Intrinsic Calculation For Schrödinger, Inc. (NASDAQ:SDGR) Suggests It's 26% Undervalued

Simply Wall St.

6 months ago

An Intrinsic Calculation For Schrödinger, Inc. (NASDAQ:SDGR) Suggests It's 26% Undervalued

Argus Research

6 months ago

SDGR: Raising target price to $27.00

Schrödinger’s Statement Regarding FDA Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs

Business Wire

7 months ago

Schrödinger’s Statement Regarding FDA Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs

Schrodinger (SDGR) Moves 27.4% Higher: Will This Strength Last?

Zacks

7 months ago

Schrodinger (SDGR) Moves 27.4% Higher: Will This Strength Last?

Argus Research

7 months ago

SDGR: Lowering target price to $19.00

Argus Research

7 months ago

SDGR: Lowering target price to $20.00

Schrödinger (NASDAQ:SDGR) Is In A Good Position To Deliver On Growth Plans

Simply Wall St.

7 months ago

Schrödinger (NASDAQ:SDGR) Is In A Good Position To Deliver On Growth Plans

Argus Research

7 months ago

SDGR: Lowering target price to $23.00

Schrödinger to Present Preclinical Data at AACR Annual Meeting

Business Wire

7 months ago

Schrödinger to Present Preclinical Data at AACR Annual Meeting

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire

7 months ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger Expands Board of Directors with Appointment of Bridget van Kralingen

Business Wire

8 months ago

Schrödinger Expands Board of Directors with Appointment of Bridget van Kralingen

Argus Research

8 months ago

SDGR: What does Argus have to say about SDGR?

Schrödinger Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

8 months ago

Schrödinger Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Thomson Reuters StreetEvents

8 months ago

Q4 2024 Schrodinger Inc Earnings Call

Schrodinger Inc (SDGR) Q4 2024 Earnings Call Highlights: Strong Software Growth Amidst Revenue ...

GuruFocus.com

8 months ago

Schrodinger Inc (SDGR) Q4 2024 Earnings Call Highlights: Strong Software Growth Amidst Revenue ...

Schrodinger, Inc. (SDGR) Reports Q4 Loss, Tops Revenue Estimates

Zacks

8 months ago

Schrodinger, Inc. (SDGR) Reports Q4 Loss, Tops Revenue Estimates

Schrödinger Reports Strong Fourth Quarter and Full-Year 2024 Financial Results

Business Wire

8 months ago

Schrödinger Reports Strong Fourth Quarter and Full-Year 2024 Financial Results

Argus Research

8 months ago

SDGR: Lowering target price to $17.00

Schrodinger Inc (SDGR) Q4 2024: Everything You Need To Know Ahead Of Earnings

GuruFocus.com

8 months ago

Schrodinger Inc (SDGR) Q4 2024: Everything You Need To Know Ahead Of Earnings

Schrödinger to Participate in Upcoming Investor Conferences

Business Wire

8 months ago

Schrödinger to Participate in Upcoming Investor Conferences

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire

8 months ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Argus Research

8 months ago

SDGR: Raising target price to $21.00

Why Xpeng (XPEV) and Schrodinger (SDGR) Are Advancing Today

Insider Monkey

8 months ago

Why Xpeng (XPEV) and Schrodinger (SDGR) Are Advancing Today

Schrodinger Stock Scores IBD Rating Upgrade

Investor's Business Daily

8 months ago

Schrodinger Stock Scores IBD Rating Upgrade

Schrödinger to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26

Business Wire

9 months ago

Schrödinger to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26

Argus Research

9 months ago

SDGR: What does Argus have to say about SDGR?

Strong week for Schrödinger (NASDAQ:SDGR) shareholders doesn't alleviate pain of five-year loss

Simply Wall St.

9 months ago

Strong week for Schrödinger (NASDAQ:SDGR) shareholders doesn't alleviate pain of five-year loss

Schrödinger (SDGR): Revolutionizing Biopharma with Quantum Mechanics and AI

Insider Monkey

9 months ago

Schrödinger (SDGR): Revolutionizing Biopharma with Quantum Mechanics and AI

Argus Research

9 months ago

SDGR: Raising target price to $20.00

Schrödinger, Inc. (SDGR): Quantum Mechanics Meets AI in Biopharma, Backed by Hunterbrook’s ‘Key AI Winner’ Endorsement

Insider Monkey

9 months ago

Schrödinger, Inc. (SDGR): Quantum Mechanics Meets AI in Biopharma, Backed by Hunterbrook’s ‘Key AI Winner’ Endorsement

Why Schrödinger, Inc. (SDGR) Is Skyrocketing Now

Insider Monkey

9 months ago

Why Schrödinger, Inc. (SDGR) Is Skyrocketing Now

Schrodinger (SDGR) Moves 14.1% Higher: Will This Strength Last?

Zacks

9 months ago

Schrodinger (SDGR) Moves 14.1% Higher: Will This Strength Last?

Why Drug Developers That Utilize AI, Including SDGR and RXRX, Are Jumping

Insider Monkey

9 months ago

Why Drug Developers That Utilize AI, Including SDGR and RXRX, Are Jumping

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire

9 months ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Argus Research

9 months ago

SDGR: Raising target price to $17.00

Argus Research

10 months ago

SDGR: Lowering target price to $15.00

Schrödinger Provides Update on Progress Across the Business and Outlines 2025 Strategic Priorities

Business Wire

10 months ago

Schrödinger Provides Update on Progress Across the Business and Outlines 2025 Strategic Priorities

Argus Research

10 months ago

SDGR: Lowering target price to $16.00

Argus Research

10 months ago

SDGR: Lowering target price to $17.00

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire

10 months ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Argus Research

a year ago

SDGR: What does Argus have to say about SDGR?

Argus Research

a year ago

SDGR: Raising target price to $18.00

Schrödinger to Present at Piper Sandler 36th Annual Healthcare Conference

Business Wire

a year ago

Schrödinger to Present at Piper Sandler 36th Annual Healthcare Conference

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire

a year ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger Broadens and Accelerates Predictive Toxicology Initiative

Business Wire

a year ago

Schrödinger Broadens and Accelerates Predictive Toxicology Initiative

Schrödinger Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

a year ago

Schrödinger Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Schrodinger announces expanded license agreement with Novartis

TipRanks

a year ago

Schrodinger announces expanded license agreement with Novartis

Schrodinger Inc (SDGR) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges and ...

GuruFocus.com

a year ago

Schrodinger Inc (SDGR) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges and ...

Thomson Reuters StreetEvents

a year ago

Q3 2024 Schrodinger Inc Earnings Call

Argus Research

a year ago

SDGR: Raising target price to $18.00

Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details

Benzinga

a year ago

Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details

Schrodinger, Inc. (SDGR) Reports Q3 Loss, Misses Revenue Estimates

Zacks

a year ago

Schrodinger, Inc. (SDGR) Reports Q3 Loss, Misses Revenue Estimates

Schrödinger Reports Third Quarter 2024 Financial Results

Business Wire

a year ago

Schrödinger Reports Third Quarter 2024 Financial Results

Schrödinger Announces Multi-Target Collaboration and Expanded Software Licensing Agreement with Novartis

Business Wire

a year ago

Schrödinger Announces Multi-Target Collaboration and Expanded Software Licensing Agreement with Novartis

Schrodinger Inc (SDGR) Q3 2024 Earnings Report Preview: What to Expect

GuruFocus.com

a year ago

Schrodinger Inc (SDGR) Q3 2024 Earnings Report Preview: What to Expect

Argus Research

a year ago

SDGR: Lowering target price to $14.00

Schrödinger to Present at Jefferies London Healthcare Conference

Business Wire

a year ago

Schrödinger to Present at Jefferies London Healthcare Conference

Schrödinger to Announce Third Quarter 2024 Financial Results on November 12

Business Wire

a year ago

Schrödinger to Announce Third Quarter 2024 Financial Results on November 12

iRhythm Technologies (IRTC) Soars 21.7%: Is Further Upside Left in the Stock?

Zacks

a year ago

iRhythm Technologies (IRTC) Soars 21.7%: Is Further Upside Left in the Stock?

Schrödinger Presents SGR-3515 Preclinical Data at 2024 EORTC-NCI-AACR Symposium

Business Wire

a year ago

Schrödinger Presents SGR-3515 Preclinical Data at 2024 EORTC-NCI-AACR Symposium

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire

a year ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger to Present New Preclinical SGR-3515 and PRMT5-MTA Data at 2024 EORTC-NCI-AACR Symposium

Business Wire

a year ago

Schrödinger to Present New Preclinical SGR-3515 and PRMT5-MTA Data at 2024 EORTC-NCI-AACR Symposium

Argus Research

a year ago

SDGR: What does Argus have to say about SDGR?

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire

a year ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger, Inc. (SDGR): A Bull Case Theory

Insider Monkey

a year ago

Schrödinger, Inc. (SDGR): A Bull Case Theory

Schrödinger, Inc. (SDGR): Among The Best Medical AI Companies

Insider Monkey

a year ago

Schrödinger, Inc. (SDGR): Among The Best Medical AI Companies

Argus Research

a year ago

SDGR: What does Argus have to say about SDGR?

Argus Research

a year ago

SDGR: Raising target price to $16.00

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire

a year ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger to Present at Morgan Stanley Global Healthcare Conference

Business Wire

a year ago

Schrödinger to Present at Morgan Stanley Global Healthcare Conference

Schrödinger Second Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

a year ago

Schrödinger Second Quarter 2024 Earnings: Beats Expectations

Thomson Reuters StreetEvents

a year ago

Q2 2024 Schrodinger Inc Earnings Call

Share on Social Networks: